Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
UCB ENXTBR:UCB |
50,35 B | 0,62% | 3/6 | 74,29% | -95,67% | 12,29% | UP |
|
Biotalys NV ENXTBR:BTLS |
0,07 B | 0,00% | 0/0 | 248,79% | 40,67% | 288,60% | DOWN |
|
European Medical Solutions ENXTBR:ALEMS |
0,02 B | 0,00% | 5/5 | 0,00% | 0,00% | -100,00% | DOWN |
|
Celyad Oncology ENXTBR:CYAD |
0,01 B | 0,00% | 2/5 | 0,00% | 0,00% | -100,00% | UP |
|
Bone Therapeutics ENXTBR:BOTHE |
0,01 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Oxurion NV ENXTBR:OXUR |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
TheraVet ENXTPA:ALVET |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |

























